+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sinus Dilation Devices Market Report by Product, Procedure, Patient Type, End User, and Region 2023-2028

  • PDF Icon

    Report

  • 144 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912090
The global sinus dilation devices market size reached US$ 3.2 Billion in 2022. Looking forward, the market is expected to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.43% during 2022-2028.

Sinus dilation, also known as balloon sinuplasty, is a minimally invasive procedure that opens blocked sinus passages, allow adequate airflow, and restore natural drainage. It relies on various implantable devices to improve the patency of sinus openings, deliver local medication, and reduce postoperative inflammation. As these devices help in quick recovery, they are gaining traction over conventional sinus devices to treat chronic rhinosinusitis (CRS) refractory worldwide. Besides this, they can be combined with other techniques for patients with significant inflammation in the ethmoid or other sinuses. Nowadays, several manufacturers are introducing devices integrated with microsensors to determine device position during surgeries.

Sinus Dilation Devices Market Trends

Factors like nasal polyps, nasotracheal tubes, allergic rhinitis, deviated septum, facial bone abnormalities, swollen adenoids, and cleft palate increase the likelihood of developing chronic sinusitis. This, coupled with a significant rise in the prevalence of these factors among the geriatric population, represents one of the key factors bolstering the market growth. In addition to this, the growing number of patients with tumors, diabetes, cystic fibrosis, ciliary dyskinesia, Kartagener syndrome, and human immunodeficiency virus (HIV) infection is contributing to market growth. Moreover, children generally have a higher risk of developing acute bronchitis, including sinusitis. This, in confluence with the increasing concerns among parents about the health of their children, is catalyzing the demand for sinus dilation surgeries and devices around the world. Apart from this, the emerging trend of minimally invasive surgeries (MIS) over conventional open surgeries is influencing the market positively. Furthermore, the improving healthcare infrastructure and rising funding to introduce novel sinus dilation devices are projected to offering lucrative growth opportunities to market players.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global sinus dilation devices market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, procedure, patient type and end user.

Breakup by Product:

  • Balloon Sinus Dilation Devices
  • Sinus Implants
  • Handheld Instruments
  • Endoscopes

Breakup by Procedure:

  • Standalone
  • Hybrid

Breakup by Patient Type:

  • Adult
  • Pediatric

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetna Inc. (CVS Health Corporation), Dalent Medical, Innaccel Technologies Pvt. Ltd, Intersect ENT Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Meril Life Sciences Pvt. Ltd, Olympus Corporation, Sinusys Corporation, Smith & Nephew plc and Stryker Corporation.

Key Questions Answered in This Report

1. What was the size of the global sinus dilation devices market in 2022?
2. What is the expected growth rate of the global sinus dilation devices market during 2023-2028?
3. What are the key factors driving the global sinus dilation devices market?
4. What has been the impact of COVID-19 on the global sinus dilation devices market?
5. What is the breakup of the global sinus dilation devices market based on the product?
6. What is the breakup of the global sinus dilation devices market based on the procedure?
7. What is the breakup of the global sinus dilation devices market based on the patient type?
8. What is the breakup of the global sinus dilation devices market based on the end user?
9. What are the key regions in the global sinus dilation devices market?
10. Who are the key players/companies in the global sinus dilation devices market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sinus Dilation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Balloon Sinus Dilation Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sinus Implants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Handheld Instruments
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Endoscopes
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Procedure
7.1 Standalone
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hybrid
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Patient Type
8.1 Adult
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pediatric
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Aetna Inc. (CVS Health Corporation)
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.2 Dalent Medical
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Innaccel Technologies Pvt. Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Intersect ENT Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Johnson & Johnson
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Karl Storz SE & Co. KG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Medtronic plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Meril Life Sciences Pvt. Ltd
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Olympus Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sinusys Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Smith & Nephew plc
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Stryker Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis

Companies Mentioned

  • Aetna Inc. (CVS Health Corporation)
  • Dalent Medical
  • Innaccel Technologies Pvt. Ltd
  • Intersect ENT Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd
  • Olympus Corporation
  • Sinusys Corporation
  • Smith & Nephew plc
  • Stryker Corporation

Methodology

Loading
LOADING...

Table Information